IKT
Inhibikase Therapeutics, Inc.NASDAQHealthcare$1.80-0.56%ClosedMarket Cap: $127.8M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
3
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Feb 24 | Aurentz Vincent | director | Sell | 255,299 | $0.00 | 510,596 |
| Tue Feb 24 | Cabell Christopher | officer: President & Head of R&D | Sell | 338,282 | $0.00 | 676,564 |
| Tue Feb 24 | Munshi Amit | director | Sell | 19,089 | $0.00 | 38,176 |
| Wed Jan 07 | Iwicki Mark T | director, officer: Chief Executive Officer | Sell | 4,982,706 | $2.01 | 4,982,706 |
| Wed Jan 07 | Cabell Christopher | officer: President & Head of R&D | Sell | 900,117 | $2.01 | 900,117 |
| Wed Jan 07 | McIntyre David | officer: Chief Financial Officer | Sell | 986,319 | $2.01 | 986,319 |
| Mon Nov 24 | Sands Capital Life Sciences Pulse Fund II, L.P. | 10 percent owner | Buy | 2,068,965 | $1.45 | 13,018,965 |
| Thu Aug 28 | Cabell Christopher | officer: President & Head of R&D | Sell | 0 | $0.00 | 1,014,846 |
| Thu Aug 28 | Aurentz Vincent | director | Sell | 0 | $0.00 | 765,895 |
| Thu Aug 28 | Munshi Amit | director | Sell | 57,265 | $0.00 | 57,265 |